PHARMAIDS PHARMACEUTICALS LTD. Share Price

PHARMAIDS PHARMACEUTICALS LTD. Share Price

BSE: 524572
|
Pharmaceuticals
|
S Cap
₹ 30.44
+₹0.80 (2.70%)
1D
Last updated 23 Sep, 2026, 10:17 IST

PHARMAIDS PHARMACEUTICALS LTD. Share Price Today

As of 23 Sep 2026, PHARMAIDS PHARMACEUTICALS LTD. share price is ₹30.44. The stock opened at ₹29.99, compared to its previous close of ₹29.64. During today's trading session, PHARMAIDS PHARMACEUTICALS LTD. share price moved in the range of ₹29.33 to ₹30.47, with an average price of ₹29.90 for the day. Looking at its last 52-week, the stock has touched a low of ₹25.60 and a high of ₹66.00.

₹29.33
2.70% up today
₹30.47
1D LOW
1D HIGH

PHARMAIDS PHARMACEUTICALS LTD. Returns Calculator

Circuit
L
H
₹23.72
₹35.56
52-week
L
H
₹25.60
₹66.00

About PHARMAIDS PHARMACEUTICALS LTD.

PHARMAIDS PHARMACEUTICALS LTD. Share Price
ISIN
INE117D01018
Sector Market Cap
₹ 104.53 Cr

Pharmaids Pharmaceuticals Limited is an India-based suppliers of a range of specialty chemicals, skin care, hospital care and generic products in the areas of orthopedic, neuro and gastro, and other. The Company is engaged in the business of trading and manufacturing of generics, bulk drugs, and intermediaries, and other. The Company operates through Bulk Drugs and Intermediates segment. Its specialty chemicals products include Retinol, DL Alpha Tocopherol, D Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10 and D-Biotin. Its skin care products include Best care hands, Hands Sanitizer, Moisturizing Cream, Skinsure Plus, SkinSure Ultra, Alcohol Gel and Barrier Cream. Its hospital care products include Xepi Rub M, Facein Spray, Sod Hypochlorite, Sanmedin, Strumen G, Strumen TRIACID, Facein Eco, Facein Power 256, Facein Spray, Sod Hypochlorite, Wipes and PPE. Its generic products include Linzomust, Benfoshine, Duojoint, and other.

PHARMAIDS PHARMACEUTICALS LTD. Financial Highlights

  • Revenue: PHARMAIDS PHARMACEUTICALS LTD. reported revenue of ₹28.17 crore in FY26 vs ₹19.55 crore in FY25. It showed an increase of 44.09% on a yearly basis.
  • Operating Profit: PHARMAIDS PHARMACEUTICALS LTD. reported an operating loss of ₹16.30 crore in FY26 vs ₹17.28 crore in FY25. It showed an increase of 5.67% on a year-on-year basis.
  • Net Profit: PHARMAIDS PHARMACEUTICALS LTD. reported a net loss of ₹11.57 crore in FY26 vs ₹13.51 crore in FY25. It showed an increase of 14.36% on a yearly basis.

PHARMAIDS PHARMACEUTICALS LTD. Quarterly Result Highlights

  • PHARMAIDS PHARMACEUTICALS LTD. reported revenue of ₹4.17 crore in Jun 2026, compared with ₹7.28 crore in Mar 2026, representing a decrease of 42.72% on a quarter-on-quarter (QoQ) basis.
  • PHARMAIDS PHARMACEUTICALS LTD. reported an operating profit of ₹2.41 crore in Jun 2026, compared with ₹1.46 crore in Mar 2026, representing an increase of 265.07% on a quarter-on-quarter (QoQ) basis.
  • PHARMAIDS PHARMACEUTICALS LTD. reported a profit of ₹1.87 crore in Jun 2026, compared with ₹1.08 crore in Mar 2026, reflecting an increase of 273.15% on a QoQ basis.
  • The earnings per share (EPS) of PHARMAIDS PHARMACEUTICALS LTD. stood at ₹3.31 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
32.99%
FII
0.00%
Other DII
0.00%
Retail and other
67.01%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
104.89
P/E
-23.71
P/B
2.19
ROE
-29.76%
D/E
0.39
ROCE
-20.97%
Div. Yield
0.00%
EPS(TTM)
-2.95
Turnover
0.11
EV/EBITDA
-65.38
Net Margin
-127.83%
Op. Margin
-127.74%
ROA
-5.07%
Quick Ratio
0.37
Curr. Ratio
0.59
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Pharmaids Pharma has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Pharmaids Pharma appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Pharmaids Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,196.0036.515.2913.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,50,390.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,967.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,888.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,00,329.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma98,803.9026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

PHARMAIDS PHARMACEUTICALS LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹27.88₹19.45₹15.11₹0.00
Other Income₹0.29₹0.10₹0.88₹0.00
Total Revenue₹28.17₹19.55₹15.99₹0.00
Total Expenses₹46.94₹36.73₹30.79₹9.91
Profit Before Tax-₹16.30-₹17.28-₹15.62-₹9.91
Tax-₹4.73-₹3.77-₹3.78-₹2.35
Profit After Tax-₹11.57-₹13.51-₹11.84-₹7.56
EPS - Basic-₹3.31-₹3.05-₹3.56-₹5.86
EPS - Diluted-₹3.31-₹3.05-₹3.56-₹5.86

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹16.30-₹17.28-₹15.62-₹9.91
Income before WC changes-₹14.03-₹12.47-₹11.74-₹9.86
Change in Assets₹10.37-₹17.54₹0.55₹6.15
Change in Liabilities-₹0.39₹14.96₹0.57-₹0.31
Change in WC₹9.97-₹2.58₹1.12₹5.84
Cash flow from Operations-₹4.06-₹15.11-₹10.62-₹4.02
Cash flow from Investing₹23.34-₹12.22-₹74.99-₹4.94
Cash flow from Financing-₹19.97₹23.36₹77.66₹21.31
Total Cash Flow-₹0.69-₹3.98-₹7.95₹12.35
Cash (Start of the year)₹0.82₹4.80₹12.75₹0.41
Cash (End of the year)₹0.13₹0.82₹4.80₹12.75

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹76.27₹98.87₹77.81₹7.07
Current Assets₹10.99₹20.99₹13.53₹17.51
Total Assets₹87.26₹119.85₹91.34₹24.59
Current Liabilities₹24.01₹28.71₹11.58₹2.13
Net Current Asset-₹13.02-₹7.73₹1.96₹15.39
Non-Current Liabilities₹15.65₹36.10₹9.27₹0.00
Equity Capital₹47.60₹55.04₹70.50₹22.46
Total Equity & Liabilities₹87.26₹119.85₹91.34₹24.59

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹10.60₹2.34₹0.03₹0.00
Other Income₹0.66₹1.02₹0.80₹0.00
Total Revenue₹11.26₹3.36₹0.82₹0.00
Total Expenses₹28.33₹11.95₹6.91₹9.91
Profit Before Tax-₹13.95-₹8.59-₹6.09-₹9.91
Tax-₹3.52-₹1.31-₹1.14-₹2.35
Profit After Tax-₹10.44-₹7.28-₹4.95-₹7.56
EPS - Basic-₹2.95-₹2.06-₹2.18-₹5.86
EPS - Diluted-₹2.95-₹2.06-₹2.18-₹5.86

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹13.95-₹8.59-₹6.09-₹9.91
Income before WC changes-₹14.01-₹6.62-₹3.44-₹9.86
Change in Assets₹9.59-₹15.16₹1.33₹6.16
Change in Liabilities₹0.88₹14.05-₹1.33-₹0.32
Change in WC₹10.48-₹1.11₹0.00₹5.84
Cash flow from Operations-₹3.53-₹7.72-₹3.44-₹4.02
Cash flow from Investing₹24.53-₹18.90-₹72.51-₹4.94
Cash flow from Financing-₹21.36₹24.64₹65.66₹21.31
Total Cash Flow-₹0.36-₹1.99-₹10.29₹12.35
Cash (Start of the year)₹0.47₹2.46₹12.75₹0.41
Cash (End of the year)₹0.11₹0.47₹2.46₹12.75

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹78.14₹102.04₹80.24₹6.27
Current Assets₹5.82₹12.68₹4.76₹18.28
Total Assets₹83.96₹114.72₹85.00₹24.55
Current Liabilities₹15.64₹15.23₹1.10₹2.12
Net Current Asset-₹9.82-₹2.55₹3.66₹16.16
Non-Current Liabilities₹14.94₹35.70₹12.84₹0.00
Equity Capital₹53.38₹63.79₹71.06₹22.43
Total Equity & Liabilities₹83.96₹114.72₹85.00₹24.55
* All values are in INR Crore
Qty
Bid
28
29.51
400
29.5
101
29.32
51
29.31
1
29.11
Ask
Qty
30.44
480
30.45
1
30.46
10
30.47
49
30.48
34
Bid Total: 581
Ask Total: 574
Buy orders: 50%
Sell orders: 50%
Bearish
1
Neutral
2
Bullish
5
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
37.94
Neutral
ATR (14)
1.84
Neutral
STOCH(9,6)
19.22
Bullish
STOCH RSI (14)
4.52
Bullish
ADX(9)
12.72
Bullish
UO(9)
21.42
Bullish
ROC(12)
-7.32
Bearish
WillR(14)
-88.44
Bullish
Period
Simple value
Exponential vaue
5D
29.67
29.74
10D
29.89
30.02
20D
30.73
30.61
50D
31.74
31.45
100D
31.44
32.3
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
PHARMAIDS PHARMACEUTICALS LTD. Share Price
PHARMAIDS PHARMACEUTICALS LTD.
Pharmaceuticals
Add Stock
Add Another

PHARMAIDS PHARMACEUTICALS LTD. Share Price FAQs

PHARMAIDS PHARMACEUTICALS LTD. share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837